Z. Abdel-razzak, P. Loyer, A. Fautrel, J. C. Gautier, L. Corcos et al., Cytokines down-regulate expression of major cytochrome P- 450 enzymes in adult human hepatocytes in primary culture, Mol Pharmacol, vol.44, pp.707-715, 1993.

G. P. Aithal and C. P. Day, Nonsteroidal Anti-Inflammatory Drug???Induced Hepatotoxicity, Clinics in Liver Disease, vol.11, issue.3, pp.563-575, 2007.
DOI : 10.1016/j.cld.2007.06.004

C. Aninat, A. Piton, D. Glaise, L. Charpentier, T. Langouet et al., EXPRESSION OF CYTOCHROMES P450, CONJUGATING ENZYMES AND NUCLEAR RECEPTORS IN HUMAN HEPATOMA HepaRG CELLS, Drug Metabolism and Disposition, vol.34, issue.1, pp.75-83, 2006.
DOI : 10.1124/dmd.105.006759
URL : https://hal.archives-ouvertes.fr/hal-00702085

S. Antherieu, P. Bachour-el-azzi, J. Dumont, Z. Abdel-razzak, C. Guguen-guillouzo et al., Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells, Hepatology, vol.35, issue.4, pp.1518-1529, 2013.
DOI : 10.1002/hep.26160
URL : https://hal.archives-ouvertes.fr/hal-00865999

S. Awasthi, S. K. Srivastava, F. Ahmad, H. Ahmad, and G. A. Ansari, Interactions of glutathione S-transferase-pi with ethacrynic acid and its glutathione conjugate, 1993.

P. Bachour-el-azzi, A. Sharanek, Z. Abdel-razzak, S. Antherieu, H. Al-attrache et al., Impact of Inflammation on Chlorpromazine-Induced Cytotoxicity and Cholestatic Features in HepaRG Cells, Drug Metabolism and Disposition, vol.42, issue.9, pp.1556-1566, 2014.
DOI : 10.1124/dmd.114.058123
URL : https://hal.archives-ouvertes.fr/hal-01134764

P. Bachour-el-azzi, A. Sharanek, A. Burban, R. Li, R. L. Guevel et al., Comparative Localization and Functional Activity of the Main Hepatobiliary Transporters in HepaRG Cells and Primary Human Hepatocytes, Toxicological Sciences, vol.145, issue.1, pp.157-168, 2015.
DOI : 10.1093/toxsci/kfv041
URL : https://hal.archives-ouvertes.fr/hal-01134682

A. T. Banks, H. J. Zimmerman, K. G. Ishak, and J. G. Harter, Diclofenac-associated hepatotoxicity: Analysis of 180 cases reported to the food and drug administration as adverse reactions, Hepatology, vol.12, issue.3, pp.820-827, 1995.
DOI : 10.1002/hep.1840220320

E. Bjornsson and R. Olsson, Suspected drug-induced liver fatalities reported to the WHO database, Digestive and Liver Disease, vol.38, issue.1, pp.33-38, 2006.
DOI : 10.1016/j.dld.2005.06.004

P. G. Board and D. Menon, Glutathione transferases, regulators of cellular metabolism and physiology, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1830, issue.5, pp.3267-3288, 2013.
DOI : 10.1016/j.bbagen.2012.11.019

R. Bort, X. Ponsoda, R. Jover, M. J. Gomez-lechon, and J. V. Castell, Diclofenac toxicity to hepatocytes: a role for drug metabolism in cell toxicity, J Pharmacol Exp Ther, vol.288, pp.65-72, 1999.

E. G. Breen, J. Mcnicholl, E. Cosgrove, J. Mccabe, and F. M. Stevens, Fatal hepatitis associated with diclofenac., Gut, vol.27, issue.11, pp.1390-1393, 1986.
DOI : 10.1136/gut.27.11.1390

V. Cerec, D. Glaise, D. Garnier, S. Morosan, B. Turlin et al., Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor, Hepatology, vol.103, issue.4, pp.957-967, 2007.
DOI : 10.1002/hep.21536
URL : https://hal.archives-ouvertes.fr/hal-00690471

F. J. De-abajo, D. Montero, M. Madurga, and L. A. Garcia-rodriguez, Acute and clinically relevant drug-induced liver injury: a population based case-control study, British Journal of Clinical Pharmacology, vol.19, issue.1, pp.71-80, 2004.
DOI : 10.1111/j.1572-0241.2002.05505.x

X. Deng, R. F. Stachlewitz, M. J. Liguori, E. A. Blomme, J. F. Waring et al., Modest inflammation enhances, 2006.

D. Gilot, P. Loyer, A. Corlu, D. Glaise, D. Lagadic-gossmann et al., Liver Protection from Apoptosis Requires Both Blockage of Initiator Caspase Activities and Inhibition of ASK1/JNK Pathway via Glutathione S-Transferase Regulation, Journal of Biological Chemistry, vol.277, issue.51, pp.49220-49229, 2002.
DOI : 10.1074/jbc.M207325200

M. J. Gomez-lechon, X. Ponsoda, E. O-'connor, T. Donato, J. V. Castell et al., Diclofenac induces apoptosis in hepatocytes by alteration of mitochondrial function and generation of ROS, Biochemical Pharmacology, vol.66, issue.11, pp.2155-2167, 2003.
DOI : 10.1016/j.bcp.2003.08.003

M. J. Gomez-lechon, X. Ponsoda, E. O-'connor, T. Donato, R. Jover et al., Diclofenac induces apoptosis in hepatocytes, Toxicology in Vitro, vol.17, issue.5-6, pp.675-680, 2003.
DOI : 10.1016/S0887-2333(03)00105-X

C. Guguen-guillouzo, J. P. Campion, P. Brissot, D. Glaise, B. Launois et al., High yield preparation of isolated human adult hepatocytes by enzymatic perfusion of the liver, Cell Biology International Reports, vol.6, issue.6, pp.625-628, 1982.
DOI : 10.1016/0309-1651(82)90187-4

A. Guillouzo and C. Guguen-guillouzo, toxicology, Expert Opinion on Drug Metabolism & Toxicology, vol.114, issue.10, pp.1279-1294, 2008.
DOI : 10.1126/science.1151526
URL : https://hal.archives-ouvertes.fr/hal-00742183

E. J. Hickey, R. R. Raje, V. E. Reid, S. M. Gross, and S. D. Ray, Diclofenac induced in vivo nephrotoxicity may involve oxidative stress-mediated massive genomic DNA fragmentation and apoptotic cell death, Free Radical Biology and Medicine, vol.31, issue.2, pp.139-152, 2001.
DOI : 10.1016/S0891-5849(01)00560-3

A. Kretz-rommel and U. A. Boelsterli, Diclofenac Covalent Protein Binding Is Dependent on Acyl Glucuronide Formation and Is Inversely Related to P450-Mediated Acute Cell Injury in Cultured Rat Hepatocytes, Toxicology and Applied Pharmacology, vol.120, issue.1, pp.155-161, 1993.
DOI : 10.1006/taap.1993.1097

N. A. Maianski, D. Roos, and T. W. Kuijpers, Bid Truncation, Bid/Bax Targeting to the Mitochondria, and Caspase Activation Associated with Neutrophil Apoptosis Are Inhibited by Granulocyte Colony-Stimulating Factor, The Journal of Immunology, vol.172, issue.11, pp.7024-7030, 2004.
DOI : 10.4049/jimmunol.172.11.7024

Y. Masubuchi, S. Nakayama, and T. Horie, Role of mitochondrial permeability transition in diclofenac-induced hepatocyte injury in rats, Hepatology, vol.57, issue.3, pp.544-551, 2002.
DOI : 10.1053/jhep.2002.31871

L. E. Ng, B. Halliwell, and K. P. Wong, Nephrotoxic cell death by diclofenac and meloxicam, Biochemical and Biophysical Research Communications, vol.369, issue.3, pp.873-877, 2008.
DOI : 10.1016/j.bbrc.2008.02.116

C. M. Oslowski and F. Urano, Measuring ER Stress and the Unfolded Protein Response Using Mammalian Tissue Culture System, Methods in enzymology, vol.490, pp.71-92, 2011.
DOI : 10.1016/B978-0-12-385114-7.00004-0

K. Pernelle, L. Guevel, R. Glaise, D. Stasio, C. G. et al., Automated detection of hepatotoxic compounds in human hepatocytes using HepaRG cells and image-based analysis of mitochondrial dysfunction with JC-1 dye, Toxicology and Applied Pharmacology, vol.254, issue.3, pp.256-266, 2011.
DOI : 10.1016/j.taap.2011.04.018
URL : https://hal.archives-ouvertes.fr/hal-00740177

S. Ramm and A. Mally, Role of drug-independent stress factors in liver injury associated with diclofenac intake, Toxicology, vol.312, pp.83-96, 2013.
DOI : 10.1016/j.tox.2013.08.002

A. Rogue, C. Lambert, C. Spire, N. Claude, and A. Guillouzo, Interindividual Variability in Gene Expression Profiles in Human Hepatocytes and Comparison with HepaRG Cells, Drug Metabolism and Disposition, vol.40, issue.1, pp.151-158, 2012.
DOI : 10.1124/dmd.111.042028
URL : https://hal.archives-ouvertes.fr/hal-00865978

R. Garcia, J. A. Tellez-molina, and M. J. , [Acute renal failure and nephrotic syndrome associated with treatment with diclofenac], Rev Clin Esp, vol.191, pp.289-290, 1992.

S. Seitz and U. A. Boelsterli, Diclofenac acyl glucuronide, a major biliary metabolite, is directly involved in small intestinal injury in rats, Gastroenterology, vol.115, issue.6, pp.1476-1482, 1998.
DOI : 10.1016/S0016-5085(98)70026-5

A. Sharanek, P. B. Azzi, H. Al-attrache, C. C. Savary, L. Humbert et al., Different Dose-Dependent Mechanisms Are Involved in Early Cyclosporine A-Induced Cholestatic Effects in HepaRG Cells, Toxicological Sciences, vol.141, issue.1, pp.244-253, 2014.
DOI : 10.1093/toxsci/kfu122
URL : https://hal.archives-ouvertes.fr/hal-01016342

C. Guillouzo, Rho-kinase/myosin light chain kinase pathway plays a key role in the impairment of bile canaliculi dynamics induced by cholestatic drugs, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01326368

A. Sharanek, A. Burban, L. Humbert, P. Bachour-el-azzi, N. Felix-gomes et al., Cellular Accumulation and Toxic Effects of Bile Acids in Cyclosporine A-Treated HepaRG Hepatocytes, Toxicological Sciences, vol.147, issue.2, pp.573-587, 2015.
DOI : 10.1093/toxsci/kfv155
URL : https://hal.archives-ouvertes.fr/hal-01187306

S. Somasundaram, Pathogenesis of diclofenac enteropathy, Gastroenterology, vol.120, issue.7, pp.1886-1887, 1885.
DOI : 10.1053/gast.2001.25307

T. W. Son, S. P. Yun, M. S. Yong, B. N. Seo, J. M. Ryu et al., Netrin-1 protects hypoxia-induced mitochondrial apoptosis through HSP27 expression via DCC- and integrin ??6??4-dependent Akt, GSK-3??, and HSF-1 in mesenchymal stem cells, Cell Death and Disease, vol.16, issue.3, p.563, 2013.
DOI : 10.1002/jcp.24084

J. Uetrecht, Evaluation of Which Reactive Metabolite, If Any, Is Responsible for a Specific Idiosyncratic Reaction, Drug Metabolism Reviews, vol.213, issue.4, pp.745-753, 2006.
DOI : 10.1172/JCI3544

S. Matsuzaki, Clinical and pathological features of a prolonged type of acute intrahepatic cholestasis, Hepatol Res, vol.37, pp.598-607, 2007.

T. Zeng, C. L. Zhang, F. Y. Song, X. L. Zhao, and K. Q. Xie, CMZ Reversed Chronic Ethanol-Induced Disturbance of PPAR-?? Possibly by Suppressing Oxidative Stress and PGC-1?? Acetylation, and Activating the MAPK and GSK3?? Pathway, PLoS ONE, vol.5, issue.6, p.98658, 2014.
DOI : 10.1371/journal.pone.0098658.s001

Y. Zhu and Q. Y. Zhang, Role of Intestinal Cytochrome P450 Enzymes in Diclofenac-Induced Toxicity in the Small Intestine, Journal of Pharmacology and Experimental Therapeutics, vol.343, issue.2, pp.362-370, 2012.
DOI : 10.1124/jpet.112.198077